Efficacy of the antiCD38 Monoclonal Antibody Isatuximab in the Treatment of PCRA by Major ABO Mismatch After Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT05559827 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05559827
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2026-10-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.